End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency

被引:8
作者
Descombes, E [1 ]
Fellay, G [1 ]
机构
[1] Hop Cantonal Fribourg, Dept Internal Med, Dialysis Unit, CH-1700 Fribourg, Switzerland
关键词
end-stage renal failure; irbesartan; diabetes; hypertension;
D O I
10.1081/JDI-100101967
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report the case of a 78-year-old hypertensive diabetic patient without evidence of renal artery stenosis who had moderate chronic renal insufficiency, which had been stable for several years under low-dose captopril therapy, and who rapidly developed acute renal failure when irbesartan was prescribed. Unfortunately the medication was not stopped promptly and the patient never recovered his basal renal function and had to undergo chronic hemodialysis. This observation emphasizes the importance of a careful monitoring of renal function in patients receiving angiotensin II receptor antagonists.
引用
收藏
页码:815 / 821
页数:7
相关论文
共 20 条
[1]   ACUTE-RENAL-FAILURE AFTER THE USE OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS IN PATIENTS WITHOUT RENAL-ARTERY STENOSIS [J].
BRIDOUX, F ;
HAZZAN, M ;
PALLOT, JL ;
FLEURY, D ;
LEMAITRE, V ;
KLEINKNECHT, D ;
VANHILLE, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (02) :100-104
[2]   Angiotensin II receptor antagonists in hypertension [J].
Burnier, M ;
Brunner, HR .
KIDNEY INTERNATIONAL, 1998, 54 :S107-S111
[3]   SHORT-TERM AND SUSTAINED RENAL EFFECTS OF ANGIOTENSIN-II RECEPTOR BLOCKADE IN HEALTHY-SUBJECTS [J].
BURNIER, M ;
HAGMAN, M ;
NUSSBERGER, J ;
BIOLLAZ, J ;
ARMAGNAC, C ;
BROUARD, R ;
WAEBER, B ;
BRUNNER, HR .
HYPERTENSION, 1995, 25 (04) :602-609
[4]   Losartan-induced azotemia in a diabetic recipient of a kidney transplant [J].
Cohen, LS ;
Friedman, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (19) :1271-1272
[5]  
DOIG JK, 1995, J CARDIOVASC PHARM, V25, P511, DOI 10.1097/00005344-199504000-00001
[6]   Losartan as an alternative to ACE inhibitors in patients with renal dysfunction [J].
Esmail, ZN ;
Loewen, PS .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (10) :1096-1098
[7]   Effects of Losartan on renal function in patients with essential hypertension [J].
Fauvel, JP ;
Velon, S ;
Berra, N ;
Pozet, N ;
Madonna, O ;
Zech, P ;
Laville, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (02) :259-263
[8]   Irbesartan - A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension [J].
Gillis, JC ;
Markham, A .
DRUGS, 1997, 54 (06) :885-902
[9]   Drug therapy - Angiotensin receptors and their antagonists [J].
Goodfriend, TL ;
Elliott, ME ;
Catt, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) :1649-1654
[10]  
Holm Ellen A., 1996, Blood Pressure, V5, P360, DOI 10.3109/08037059609078075